{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:22:54Z","timestamp":1778030574611,"version":"3.51.4"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T00:00:00Z","timestamp":1433721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0128744","type":"journal-article","created":{"date-parts":[[2015,6,8]],"date-time":"2015-06-08T18:11:13Z","timestamp":1433787073000},"page":"e0128744","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Inhibition of Glycoprotein VI Clustering by Collagen as a Mechanism of Inhibiting Collagen-Induced Platelet Responses: The Example of Losartan"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct00763893","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Peng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Loyau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Tchitchinadze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Ropers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Jondeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Jandrot-Perrus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,6,8]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","article-title":"Platelet-collagen interaction: is GPVI the central receptor?","volume":"102","author":"B Nieswandt","year":"2003","journal-title":"Blood"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0092-8674(00)81607-4","article-title":"Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow","volume":"94","author":"B Savage","year":"1998","journal-title":"Cell"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/ATVBAHA.111.241067","article-title":"Platelet glycoprotein VI dimerization, an active process inducing receptor competence, is an indicator of platelet reactivity","volume":"32","author":"S Loyau","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"41","key":"ref4","doi-asserted-by":"crossref","first-page":"29019","DOI":"10.1074\/jbc.274.41.29019","article-title":"The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors","volume":"274","author":"JM Clemetson","year":"1999","journal-title":"J Biol Chem"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1182\/blood.V96.5.1798","article-title":"Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily","volume":"96","author":"M Jandrot-Perrus","year":"2000","journal-title":"Blood"},{"issue":"24","key":"ref6","doi-asserted-by":"crossref","first-page":"21561","DOI":"10.1074\/jbc.M201012200","article-title":"Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling","volume":"277","author":"K Suzuki-Inoue","year":"2002","journal-title":"J Biol Chem"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/j.1538-7836.2003.00495.x","article-title":"Human platelet glycoprotein VI function is antagonized by monoclonal anti body-derived Fab fragments","volume":"1","author":"C Lecut","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1160\/TH05-11-0731","article-title":"Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo","volume":"95","author":"A Bultmann","year":"2006","journal-title":"Thromb Haemost"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI114318","article-title":"A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion","volume":"84","author":"M Moroi","year":"1989","journal-title":"J Clin Invest"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1365-2141.1995.tb08900.x","article-title":"Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency","volume":"89","author":"M Arai","year":"1995","journal-title":"Br J Haematol"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.thromres.2005.08.001","article-title":"GPVI-deficient mice lack collagen responses and are protected against experimentally induced pulmonary thromboembolism","volume":"118","author":"S Lockyer","year":"2006","journal-title":"Thromb Res"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-0030-1251505","article-title":"Diagnostic and therapeutic potentials of platelet glycoprotein VI","volume":"36","author":"B Bigalke","year":"2010","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0090-6980(92)90070-A","article-title":"DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2\/prostaglandin H2 (TP) receptors","volume":"44","author":"EC Liu","year":"1992","journal-title":"Prostaglandins"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00005344-199808000-00005","article-title":"Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats","volume":"32","author":"P Li","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4 Pt 1","key":"ref15","first-page":"705","article-title":"Losartan inhibits the adhesion of rat platelets to fibrillar collagen\u2014a potential role of nitric oxide and prostanoids","volume":"51","author":"T Matys","year":"2000","journal-title":"J Physiol Pharmacol"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/ATVBAHA.106.138693","article-title":"EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis","volume":"27","author":"C Grothusen","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1021\/jm901534d","article-title":"Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI","volume":"53","author":"K Ono","year":"2010","journal-title":"J Med Chem"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"e101209","DOI":"10.1371\/journal.pone.0101209","article-title":"Discovery of novel GPVI receptor antagonists by structure-based repurposing","volume":"9","author":"L Taylor","year":"2014","journal-title":"PLoS ONE"},{"issue":"48","key":"ref19","doi-asserted-by":"crossref","first-page":"46197","DOI":"10.1074\/jbc.M204029200","article-title":"Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI)with collagen\u2014A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen","volume":"277","author":"Y Miura","year":"2002","journal-title":"J Biol Chem"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jmb.2006.06.053","article-title":"Chimeric Fc receptors identify ligand binding regions in human glycoprotein VI","volume":"361","author":"B Dumont","year":"2006","journal-title":"J Mol Biol"},{"issue":"50","key":"ref21","doi-asserted-by":"crossref","first-page":"52293","DOI":"10.1074\/jbc.M406342200","article-title":"Identification of residues within human glycoprotein VI involved in the binding to collagen\u2014Evidence for the existence of distinct binding sites","volume":"279","author":"C Lecut","year":"2004","journal-title":"J Biol Chem"},{"issue":"18","key":"ref22","doi-asserted-by":"crossref","first-page":"15316","DOI":"10.1074\/jbc.M009117200","article-title":"Expression and function of the collagen receptor GPVI during megakaryocyte maturation","volume":"276","author":"AH Lagrue-Lak-Hal","year":"2001","journal-title":"J Biol Chem"},{"issue":"43","key":"ref23","doi-asserted-by":"crossref","first-page":"27035","DOI":"10.1074\/jbc.272.43.27035","article-title":"Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1","volume":"272","author":"M Jandrot-Perrus","year":"1997","journal-title":"J Biol Chem"},{"issue":"2","key":"ref24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ab.2011.06.036","article-title":"Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential","volume":"417","author":"M Zahid","year":"2011","journal-title":"Anal Biochem"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.acvd.2010.04.008","article-title":"Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome","volume":"103","author":"D Detaint","year":"2010","journal-title":"Archives of cardiovascular diseases"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1527-3466.1997.tb00327.x","article-title":"EXP3174: The Major Active Metabolite of Losartan","volume":"15","author":"T Tamaki","year":"1997","journal-title":"Cardiovasc Drug Rev"},{"issue":"32","key":"ref27","doi-asserted-by":"crossref","first-page":"24560","DOI":"10.1074\/jbc.M004111200","article-title":"Micromolar Ca2+ concentrations are essential for Mg2+-dependent binding of collagen by the integrin alpha 2beta 1 in human platelets","volume":"275","author":"DJ Onley","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1074\/jbc.275.1.35","article-title":"The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens","volume":"275","author":"CG Knight","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood.V91.2.491","article-title":"Glycoprotein VI is a major collagen receptor for platelet activation: It recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb\/IIIa, and von Willebrand factor do not","volume":"91","author":"B Kehrel","year":"1998","journal-title":"Blood"},{"issue":"35","key":"ref30","doi-asserted-by":"crossref","first-page":"30000","DOI":"10.1074\/jbc.M112.359125","article-title":"Constitutive dimerization of glycoprotein VI (GPVI) in resting platelets is essential for binding to collagen and activation in flowing blood","volume":"287","author":"SM Jung","year":"2012","journal-title":"J Biol Chem"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood-2006-01-010215","article-title":"Structural basis for platelet collagen responses by the immune-type receptor glycoprotein VI","volume":"108","author":"K Horii","year":"2006","journal-title":"Blood"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1517\/14728222.12.6.677","article-title":"Novel mechanistic concept of platelet inhibition","volume":"12","author":"AB Sigalov","year":"2008","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/01.HYP.0000034745.98129.EC","article-title":"Angiotensin II AT1 receptor antagonists inhibit platelet adhesion and aggregation by nitric oxide release","volume":"40","author":"L Kalinowski","year":"2002","journal-title":"Hypertension"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.jhh.1001102","article-title":"Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan","volume":"14","author":"IA Jagroop","year":"2000","journal-title":"J Hum Hypertens"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/HYPERTENSIONAHA.110.158220","article-title":"Angiotensin II-mediated microvascular thrombosis","volume":"56","author":"EY Senchenkova","year":"2010","journal-title":"Hypertension"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V97.12.3829","article-title":"Evidence for cross-talk between glycoprotein VI and Gi-coupled receptors during collagen-induced platelet aggregation","volume":"97","author":"B Nieswandt","year":"2001","journal-title":"Blood"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"C1469","DOI":"10.1152\/ajpcell.00380.2009","article-title":"Thromboxane prostanoid receptor stimulation induces shedding of the transmembrane chemokine CX3CL1 yet enhances CX3CL1-dependent leukocyte adhesion","volume":"298","author":"S Tole","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbamem.2013.12.012","article-title":"Insights into the molecular basis of action of the AT1 antagonist losartan using a combined NMR spectroscopy and computational approach","volume":"1838","author":"M Zervou","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/clpt.1992.56","article-title":"Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist","volume":"51","author":"A Munafo","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1074248411425491","article-title":"Characterization of the in vivo antiplatelet activity of the antihypertensive agent losartan","volume":"17","author":"JP Murad","year":"2012","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"5770","key":"ref41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"JP Habashi","year":"2006","journal-title":"Science"},{"issue":"26","key":"ref42","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"BS Brooke","year":"2008","journal-title":"N Engl J Med"},{"issue":"9","key":"ref43","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.amjcard.2013.06.019","article-title":"Usefulness of losartan on the size of the ascending aorta in an unselected cohort of children, adolescents, and young adults with Marfan syndrome","volume":"112","author":"C Pees","year":"2013","journal-title":"Am J Cardiol"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1291\/hypres.31.1711","article-title":"Low-dose losartan therapy reduces proteinuria in normotensive patients with immunoglobulin A nephropathy","volume":"31","author":"A Shimizu","year":"2008","journal-title":"Hypertens Res"},{"issue":"6","key":"ref45","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1016\/j.ejim.2011.08.021","article-title":"Renin-angiotensin system inhibitors reduce the progression of mesangioproliferative glomerulonephritis: 10 year follow-up","volume":"22","author":"P Presta","year":"2011","journal-title":"European journal of internal medicine"},{"issue":"11 Suppl 1","key":"ref46","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1161\/CIRCULATIONAHA.111.082610","article-title":"Modulation of transforming growth factor-beta signaling and extracellular matrix production in myxomatous mitral valves by angiotensin II receptor blockers","volume":"126","author":"A Geirsson","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/ATVBAHA.107.158576","article-title":"Dilation-dependent activation of platelets and prothrombin in human thoracic ascending aortic aneurysm","volume":"28","author":"Z Touat","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2353\/ajpath.2010.091143","article-title":"Platelet recruitment to the inflamed glomerulus occurs via an alphaIIbbeta3\/GPVI-dependent pathway","volume":"177","author":"S Devi","year":"2010","journal-title":"Am J Pathol"},{"key":"ref49","article-title":"Antithrombotic effects of losartan in patients with hypertension complicated by atrial fibrillation: 4A (Angiotensin II Antagonist of platelet Aggregation in patients with Atrial fibrillation), a pilot study","author":"T Sakamoto","year":"2014","journal-title":"Hypertens Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0128744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T04:47:26Z","timestamp":1599108446000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0128744"}},"subtitle":[],"editor":[{"given":"Christian","family":"Schulz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,8]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0128744","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,8]]}}}